Will this spin-off stock continue to slay FTSE 100 giants?

Roland Head asks if this potential FTSE 100 (INDEXFTSE:UKX) giant killer is worth the risk. More »

3 FTSE 100 stocks I’d never sell

There are some FTSE 100 (INDEXFTSE:UKX) shares that really do deserve to be held forever. More »

Is this the FTSE 100’s top growth stock?

This FTSE 100 (INDEXFTSE: UKX) unsung hero good could be a top growth pick, says G A Chester. More »

3 great income stocks I’d buy today

If you are looking for a base rate busting income these three FTSE 100 companies are a great place to start, says Harvey Jones. More »

A FTSE 100 giant with 20% upside to consider

This blue chip could have a possible upside of 20%. More »

Are shares in GlaxoSmithKline plc now in bargain territory?

Paul Summers casts his eyes over today's results from pharmaceutical giant GlaxoSmithKline plc (LON:GSK). More »

Should you buy or sell AstraZeneca plc after FY sales fall 5%?

Roland Head reviews 2016 results from AstraZeneca plc (LON:AZN) and asks whether the firm's ambitious goals deserve a buy rating. More »

After revenue jumps 60%, is Oxford Biodynamics plc a buy?

Could Oxford Biodynamics PLC (LON: OBD) be London's next super growth stock? More »

2 hot FTSE 100 dividend stocks I’d buy in February

These two shares offer excellent income potential. More »

Is Neil Woodford a fool to continue pumping money into Capita plc and AstraZeneca plc?

Are Capita plc (LON:CPI) and AstraZeneca plc (LON:AZN) poor investments today? More »

Why I see 50% upside in this pharmaceutical firm in 2017

Bilaal Mohamed explains why this pharamceutical firm could have massive growth potential over the coming year. More »

Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)? More »

Is Neil Woodford’s favourite stock set to outperform in 2017?

Neil Woodford loves this company, but should you be buying? More »

2 healthcare stocks that could make you rich in 2017

These two companies offer bright futures at fair valuations. More »

My 3 top dividend stocks for Christmas

Tucking away some tasty dividends for Christmas can help you to a prosperous New Year. More »

Why Eco Animal Health Group Plc is set to outperform AstraZeneca plc in 2017

Eco Animal Health Group Plc (LON: EAH) has more appeal than AstraZeneca plc (LON: EAH). More »

Why I believe these 3 stocks will struggle in 2017

These three companies are in danger of generating losses for investors next year. More »

3 cheap blue chips for December

Are these Footsie favourites now unmissable bargains? More »

4 dividend stocks to put on your 2017 shopping list

Royston Wild reveals a cluster of London stocks with exceptional dividend potential. More »

Is ReNeuron Group plc a better buy than AstraZeneca plc?

Should you ditch AstraZeneca plc (LON: AZN) in favour of ReNeuron Group plc (LON: RENE)? More »